2010: 103/1 (Jan) pp. 1–249

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

32 articles
1.
Moving forward with a new Editorial team for Thrombosis and Haemostasis

C. Weber (1), G. Y. H. Lip (2)

(1) Insitute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany; (2) Haemostasis Thrombosis and Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

Thrombosis and Haemostasis 2010 103 1: 1-2

[Summary] [Free download]
2.
Editor´s choice articles 2008–2009

G. Y. H. Lip (1), K. T. Preissner (2), C. Weber (3)

(1) Haemostasis Thrombosis & Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK; (2) Institute for Biochemistry, Justus Liebig University, Giessen, Germany; (3) Institute for Molecular Cardiovascular Research (IMCAR), RWTH Aachen University, Aachen, Germany

Thrombosis and Haemostasis 2010 103 1: 3-6

[Summary] [Free download]
3.
Tissue factor inhibition: Another approach reducing thrombosis after vascular injury

I. Ott (1)

(1) 1. Medizinische Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany

Thrombosis and Haemostasis 2010 103 1: 7-8

http://dx.doi.org/10.1160/TH09-10-0712

[Summary] [Free download]
4.
Testosterone, tissue factor inhibition and vascular aging

F. Andreotti (1), G. Ferrante (1), F. Crea (1)

(1) Institute of Cardiology, Gemelli University Hospital, Rome, Italy

Thrombosis and Haemostasis 2010 103 1: 9-10

http://dx.doi.org/10.1160/TH09-11-0778

[Summary] [Free download]
5.
Glycoprotein inhibitors in patients on chronic anticoagulation: Safe enough or too much risk?

F. Marín (1), B. Bonacasa (1), M. Valdés (1)

(1) Derpartment of Cardiology, Hospital Universitario Virgen de la Arrixaca, Universidad de Murcia, Murcia, Spain

Thrombosis and Haemostasis 2010 103 1: 11-12

http://dx.doi.org/10.1160/TH09-10-0694

[Summary] [Free download]
6.
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
A Consensus Document of the European Society of Cardiology Working Group onThrombosis, endorsed by the European Heart Rhythm Association [EHRA] and the European Association of Percutaneous Cardiovascular Interventions [EAPCI]

Online Supplementary Material

G. Y. H. Lip, K. Huber (1), F. Andreotti (2), H. Arnesen (3), K. J. Airaksinen (4), T. Cuisset (5), P. Kirchhof (6), F. Marín (7)

(1) 3rd Department of Medicine, Cardiology and Emergency Medicine, Wilhelminenhospital, Vienna, Austria; (2) Institute of Cardiology, Gemelli University Hospital, Rome, Italy; (3) Department of Cardiology, Oslo University Hospital, Ullevål, Oslo, Norway; (4) Department of Medicine, Turku University Hospital, Turku, Finland; (5) Department of Cardiology, CHU Timone, Marseille, France; (6) Department of Cardiology and Angiology, Universitätsklinikum Münster, Münster, Germany; (7) Department of Cardiology, Hospital Universitario Virgen de la Arrixaca, Ctra Madrid-Cartagena s/n, Murcia, Spain

Thrombosis and Haemostasis 2010 103 1: 13-28

http://dx.doi.org/10.1160/TH09-08-0580

[Summary] [Free download]
7.
Application of platelet function testing to the bedside

C. D. Williams (1), G. Cherala (1), V. L. Serebruany (2)

(1) Department of Pharmacy Practice, Oregon State University and Oregon Health and Science University College of Pharmacy, Portland, Oregon, USA; (2) HeartDrug Research, Johns Hopkins University, Towson, Maryland, USA

Thrombosis and Haemostasis 2010 103 1: 29-33

http://dx.doi.org/10.1160/TH09-06-0375

[Summary] [Free download]
8.
The clinical implications of new oral anticoagulants: Will the potential advantages be achieved?

K. W. Phillips (1), J. Ansell (2)

(1) Department of Pharmacy, Boston Medical Center, Boston, Massachusetts, USA; (2) Department of Medicine, Lenox Hill Hospital, New York, New York, USA

Thrombosis and Haemostasis 2010 103 1: 34-39

http://dx.doi.org/10.1160/TH09-06-0361

[Summary] [Free download]
9.
Driving Rho GTPase activity in endothelial cells regulates barrier integrity

C. M. L. Beckers (1), V. W. M. van Hinsbergh (1), G. P. van Nieuw Amerongen (1)

(1) Department for Physiology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, the Netherlands

Thrombosis and Haemostasis 2010 103 1: 40-55

http://dx.doi.org/10.1160/TH09-06-0403

[Summary] [Free download]
10.
Endothelium, venous thromboembolism and ischaemic cardiovascular events

P. Gresele (1), S. Momi (1), R. Migliacci (2)

(1) Division of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Italy; (2) Division of Internal Medicine, Ospedale della Valdichiana“S.Margherita”, Cortona, Italy

Thrombosis and Haemostasis 2010 103 1: 56-61

http://dx.doi.org/10.1160/TH09-08-0562

[Summary] [Free download]
11.
New oral anticoagulants in development

J. I. Weitz (1)

(1) Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University and Henderson Research Centre, Hamilton,Ontario, Canada

Thrombosis and Haemostasis 2010 103 1: 62-70

http://dx.doi.org/10.1160/TH09-07-0434

[Summary] [Free download]
12.
Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients

J. B. Muhlestein (1)

(1) Cardiovascular Department, Intermountain Medical Center, University of Utah School of Medicine, Salt Lake City, Utah, USA

Thrombosis and Haemostasis 2010 103 1: 71-82

http://dx.doi.org/10.1160/TH09-03-0177

[Summary] [Free download]
13.
[Remove from basket]
HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions

C. A. Kretz (1), K. Cuddy (1), A. R. Stafford (1), J. C. Fredenburgh (1), R. Roberts (1), J. I. Weitz (1)

(1) Departments of Medicine and Biochemistry and Biomedical Sciences, McMaster University and Henderson Research Centre, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2010 103 1: 83-93

http://dx.doi.org/10.1160/TH09-04-0237

[Summary] [PDF] [Pay per view]
14.
[Remove from basket]
Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity

M. Takeyama (1), K. Nogami (1), T. Matsumoto (1), T. Soeda (2), T. Suzuki (2), K. Hattori (2), M. Shima (1)

(1) Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; (2) Chugai Pharmaceutical Co. Ltd., Fuji-Gotemba Research Laboratories, Gotemba, Shizuoka, Japan

Thrombosis and Haemostasis 2010 103 1: 94-102

http://dx.doi.org/10.1160/TH09-05-0338

[Summary] [PDF] [Pay per view]
15.
[Remove from basket]
Alteration of fibrin clot properties by ultrafine particulate matter

S. Metassan (1, 2), A. J. Charlton (1, 2), M. N. Routledge (1), D. J. A. Scott (2), R. A. S. Ariens (2)

(1) Molecular Epidemiology Unit, Leeds Institute for Health, Genetics and Therapeutics, Faculty of Medicine and Health, University of Leeds, UK; (2) Section on Mechanisms of Thrombosis, Division of Cardiovascular and Diabetes Research, Leeds Institute for Health, Genetics and Therapeutics, Faculty of Medicine and Health, University of Leeds, UK

Thrombosis and Haemostasis 2010 103 1: 103-113

http://dx.doi.org/10.1160/TH09-05-0330

[Summary] [PDF] [Pay per view]
16.
[Remove from basket]
Thrombin generation as an intermediate phenotype for venous thrombosis
A proof-of-concept study

O. Segers (1), R. van Oerle (2), H. ten Cate (2), J. Rosing (1), E. Castoldi (1)

(1) Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands; (2) Department of Internal Medicine, Laboratory for Clinical Thrombosis and Haemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, theNetherlands

Thrombosis and Haemostasis 2010 103 1: 114-122

http://dx.doi.org/10.1160/TH09-06-0356

[Summary] [PDF] [Pay per view]
17.
[Remove from basket]
High incidence of in-hospital pulmonary embolism following joint arthroplasty with dalteparin prophylaxis
A chart review

J. Kerr (1), L.-A. Linkins (1)

(1) McMaster University, Hamilton, Ontario, Canada

Thrombosis and Haemostasis 2010 103 1: 123-128

http://dx.doi.org/10.1160/TH09-07-0438

[Summary] [PDF] [Pay per view]
18.
[Remove from basket]
Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery
A decision analysis

M. Blondon (1), A. Perrier (1), M. Nendaz (1), M. Righini (2), F. Boehlen (2), M. Boulvain (3), P. De Moerloose (2)

(1) Division of General Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland; (2) Division of Angiology and Hemostasis, Department of Internal Medicine, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland; (3) Department of Gynaecology and Obstetrics, Geneva University Hospital and Faculty of Medicine, Geneva, Switzerland

Thrombosis and Haemostasis 2010 103 1: 129-137

http://dx.doi.org/10.1160/TH09-06-0349

[Summary] [PDF] [Pay per view]
19.
[Remove from basket]
Effect of compression stockings on venous blood velocity and blood flow

P. D. Stein (1), F. Matta (1), A. Y. Yaekoub (2), S. T. Ahsan (3), A. Badshah (2), F. Younas (2), J. E. Denier (3)

(1) Department of Internal Medicine, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA; (2) Department of Internal Medicine, St. Joseph Mercy Oakland Hospital, Pontiac, Michigan, USA; (3) Department of Radiology, St. Joseph Mercy Oakland Hospital, Pontiac, Michigan, USA

Thrombosis and Haemostasis 2010 103 1: 138-144

http://dx.doi.org/10.1160/TH09-06-0365

[Summary] [PDF] [Pay per view]
20.
[Remove from basket]
Effectiveness of a new immuno-assay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies

C. Pouplard (1), D. Leroux (1), S. Regina (1, 2), J. Rollin (1), Y. Gruel (1, 2)

(1) Department of Haematology-Haemostasis, CHRU of Tours, Tours Cedex, France; (2) INSERM U618, University François Rabelais of Tours, Tours, France

Thrombosis and Haemostasis 2010 103 1: 145-150

http://dx.doi.org/10.1160/TH09-04-0253

[Summary] [PDF] [Pay per view]
  1-20 21-32
Next page

Articles

You've 1010 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...